Abstract
The still experimental nature of prenatal gene therapy carries a certain degree of risk, both for the pregnant mother as well as for the fetus. Some of the risks are procedural hazards already known from more conventional fetal medicine interventions. Others are more specific to gene therapy such as the potential for interference with normal fetal development, the possibility of inadvertent germ line gene transfer, and the danger of oncogenesis. This chapter reviews the potential risks in relation to the expected benefits of prenatal gene therapy. It discusses the scientific, ethical, legal, and social implications of this novel preventive approach to genetic disease and outlines preconditions to be met in preparation for a potential future clinical application.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Coutelle C, Douar A-M, College WH, Froster U (1995) The challenge of fetal gene therapy. Nat Med 1:864–866
Waddington S, Nivsarkar M, Mistry A, Buckley SMK, Al-Allaf F, Bigger B, Holder M, Kemball-Cook G, Mosley KL, Brittan M, Ali R, Gregory L, Cook HT, Thrasher A, Tuddenham EGD, Themis M, Coutelle C (2004) Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104:2714–2721
Mattar CN, Nathwani AC, Waddington SN, Dighe N, Kaeppel C, Nowrouzi A, McIntosh J, Johana NB, Ogden B, Fisk NM, Davidoff AM, David A, Peebles D, Valentine MB, Appelt JU, von Kalle C, Schmidt M, Biswas A, Choolani M, Chan JK (2011) Stable human FIX expression after 0.9G intrauterine gene transfer of self-complementary adeno-associated viral vector 5 and 8 in Macaques. Mol Ther 9:1950–1960
Kimmelman J (2010) Gene transfer and the ethics of first-in-human research. Cambridge University Press, Cambridge
RAC (2000) Prenatal gene transfer: scientific medical and ethical issues, a report of the Recombinant DNA Advisory Committee. Hum Gene Ther 11:1211–1229
Couzin J (1998) RAC confronts in utero gene therapy proposal. Science 282:27
Zanjani ED, Anderson WF (1999) Prospects for in utero human gene therapy. Science 285:2084–2088
Committee, GTA (1998) Report on the potential use of gene therapy in utero. Department of Health, London. Available at: http://www.advisorybodies.doh.gov.uk/genetics/gtac/inutero.htm. Accessed 2 Feb 2011
Roberts MA (1998) Child versus childmaker: future persons and present duties in ethics and the law New York: Rowman and Littlefield. Rowman and Littlefield, New York
Scott R (2002) Rights, duties and the body: law and ethics of the maternal-fetal conflict. Hart, Oxford
Dickenson DLe (2002) Ethical issues in maternal–fetal medicine. Cambridge University Press, Cambridge
Peters PG Jr (2004) How safe is safe enough? Obligations to the children of reproductive technology. Oxford University Press, Oxford
Todd S (2010) Actions arising from birth. In: Grubb A, Laing J, McHale J (eds) Principles of medical law, 3rd edn. Oxford University Press, Oxford, pp 265–323
David A, Ashcroft R (2009) Placental gene therapy. Obstet Gynaecol Reprod Med 19: 296–298
Endo M, Henriques-Coelho T, Zoltick PW, Stitelman DH, Peranteau WH, Radu A, Flake AW (2010) The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors. Gene Ther 17: 61–71
Gonzaga S, Henriques-Coelho T, Davey M, Zoltick PW, Leite-Moreira AF, Correia-Pinto J, Flake AW (2008) Cystic adenomatoid malformations are induced by localized FGF10 overexpression in fetal rat lung. Am J Respir Cell Mol Biol 39:346–355
Tarantal AF, Chen H, Shi TT, Lu CH, Fang AB, Buckley S, Kolb M, Gauldie J, Warburton D, Shi W (2010) Overexpression of TGF-{beta}1 in foetal monkey lung results in prenatal pulmonary fibrosis. Eur Respir J 36:907–914
Toscano MG, Romero Z, Munoz P, Cobo M, Benabdellah K, Martin F (2011) Physiological and tissue-specific vectors for treatment of inherited diseases. Gene Ther 18:117–127
Tizzano EF, Chitayat D, Buchwald M (1993) Cell-specific localization of CFTR mRNA shows developmentally regulated expression on human fetal tissues. Hum Mol Genet 2: 219–224
Tizzano E, O’Brodovich H, Chitayat D, Benichou J, Buchwald M (1994) Regional expression of CFTR in developing human respiratory tissues. Am J Respir Cell Mol Biol 10:355–362
Broackes-Carter FC, Mouchel N, Gill D, Hyde S, Bassett J, Harris A (2002) Temporal regulation of CFTR expression during ovine lung development: implications for CF gene therapy. Hum Mol Genet 11:125–131
Hassan HJ, Leonardi A, Chelucci C, Mattia G, Macioce G, Guerriero R, Russo G, Mannucci PM, Peschle C (1990) Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood 76:1158–1164
Mibashan RS, Rodeck CH, Thumpston JK, Edwards RJ, Singer JD, White JM, Campbell S (1979) Plasma assay of fetal factors VIIIC and IX for prenatal diagnosis of haemophilia. Lancet 1:1309–1311
Rasko JEJ, O’Sullivan GM, Ankeny RA (eds) (2006) The ethics of inheritable genetic modification: a dividing line? Cambridge University Press, Cambridge
Gillman J (1948) The development of the gonads in man, with a consideration of the role of fetal endocrines and histogenesis of ovarian tumours. Contrib Embryol 32:81–92
Seppen J, van der Rijt R, Looije N, van Til NP, Lamers WH, Oude Elferink RP (2003) Long-term correction of bilirubin UDPglucuronyltransferase deficiency in rats by in utero lentiviral gene transfer. Mol Ther 8: 593–599
Manno CS, Arruda VR, Pierce GF, Glader B, Ragni M, Rasko J, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12:342–347
Arruda VR, Fields PA, Milner R, Wainwright L, De Miguel MP, Donovan PJ, Herzog RW, Nichols TC, Biegel JA, Razavi M, Dake M, Huff D, Flake AW, Couto L, Kay MA, High KA (2001) Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Mol Ther 4:586–592
Jakob M, Muhle C, Park J, Weiss S, Waddington S, Schneider H (2005) No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery. J Gene Med 7:630–637
Porada C, Tran N, Eglitis M, Moen RC, Troutman L, Flake AW, Zhao Y, Anderson WF, Zanjani ED (1998) In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther 9:1571–1585
Ye X, Gao GP, Pabin C, Raper SE, Wilson JM (1998) Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse. Hum Gene Ther 9:2135–2142
Kazazian H (1999) An estimated frequency of endogenous insertional mutations in humans. Nat Genet 22:130
Schuettrumpf J, Liu JH, Couto LB, Addya K, Leonard DG, Zhen Z, Summer J, Arruda VR (2006) Inadvertent germline transmission of AAV2 vector: findings in a rabbit model correlate with those in a human clinical trial. Mol Ther 13:1064–1073
Park PJ, Colletti E, Ozturk F, Wood JA, Tellez J, Almeida-Porada G, Porada C (2009) Factors determining the risk of inadvertent retroviral transduction of male germ cells after in utero gene transfer in sheep. Hum Gene Ther 20: 201–215
Themis M, Waddington SN, Schmidt M, von Kalle C, Wang Y, Al-Allaf F, Gregory L, Nivsarkar M, Themis M, Holder M, Buckley SMK, Dighe N, Ruthe A, Mistry A, Bigger B, Rahim A, Nguyen TH, Trono D, Thrasher AJ, Coutelle C (2005) Oncogenesis following delivery of a non-primate lentiviral gene therapy vector to fetal mice Molecular Therapy. Mol Ther 12: 763–771
Fletcher J, Richter G (1996) Human fetal gene therapy: moral and ethical questions. Hum Gene Ther 7:1605–1614
Scott R (2007) Choosing between possible lives: law and ethics of prenatal and preimplantation genetic diagnosis. Hart, Oxford
Wilkinson S (2010) Choosing tomorrow’s children: the ethics of selective reproduction. Oxford University Press, Oxford
Gelbaya TA (2010) Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb) 13:19–27
Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R (2010) Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat 31:1240–1250
Adzick N, Thom EA, Spong CY, Brock JW, Burrows PK, Johnson MP, Howell LJ, Farrell JA, Dabrowiak ME, Sutton LN, Gupta N, Tulipan NB, D’Alton ME, Farmer DL, the MOMS Investigators, N. E. J. M. F. E. a. o (2011) A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:994–1004
Flake A (2001) Prenatal intervention: ethical considerations for life-threatening and non-life-threatening anomalies. Semin Pediatr Surg 10:212–221
Strong C (2011) Regulatory and ethical issues for phase I in utero gene transfer studies. Hum Gene Ther 22:1323–1330
Tsui NB, Kadir RA, Chan KC, Chi C, Mellars G, Tuddenham EG, Leung TY, Lau TK, Chiu RW, Lo YM (2011) Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 117:3684–3691
Ashcroft RE, Viens AM (2008) Clinical trials. In: The Cambridge textbook of bioethics. Singer PA, Viens AM (eds) Cambridge University Press, Cambridge, pp 201–206
Green RM (2008) Embryo and fetal research. In: The Cambridge textbook of bioethics. Singer PA, Viens AM (eds) Cambridge University Press, Cambridge, pp 231–237
Meslin EM, Dickens BM (2008) Research ethics. In: The Cambridge textbook of bioethics. Singer PA, Viens AM (eds) Cambridge University Press, Cambridge, pp 187–193
Evans JH (2002) Playing God? Human genetic engineering and the rationalization of public bioethical debate 1959–1995. University of Chicago Press, Chicago
Wright S (1994) Molecular politics: developing American and British regulatory policy for genetic engineering, 1972–1982. University of Chicago Press, Chicago
Shakespeare TW (2006) Disability rights and wrongs. Routledge, London
Scully JL (2008) Disablity bioethics: moral bodies, moral difference New York Rowman and Littlefield. Rowman and Littlefield, New York
Jasanoff S (2005) Designs on nature: science and democracy in Europe and the United States. Princeton University Press, Princeton
Bauer M, Gaskell G (eds) (2002) Biotechnology: the making of a global controversy. Cambridge University Press, Cambridge
Sugarman J, Sulmasy DF (eds) (2001) Methods in medical ethics. Georgetown University Press, Washington, DC
Acknowledgements
The authors wish to thank Alan Flake, Anna David, and Donald Peebles for valuable commments and suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC.
About this protocol
Cite this protocol
Coutelle, C., Ashcroft, R. (2012). Risks, Benefits and Ethical, Legal, and Societal Considerations for Translation of Prenatal Gene Therapy to Human Application. In: Coutelle, C., Waddington, S. (eds) Prenatal Gene Therapy. Methods in Molecular Biology, vol 891. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-873-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-61779-873-3_17
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-872-6
Online ISBN: 978-1-61779-873-3
eBook Packages: Springer Protocols